An inhibitor of oxidative phosphorylation exploits cancer vulnerability JR Molina, Y Sun, M Protopopova, S Gera, M Bandi, C Bristow, T McAfoos, ... Nature medicine 24 (7), 1036-1046, 2018 | 747 | 2018 |
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia SO Ciurea, MJ Zhang, AA Bacigalupo, A Bashey, FR Appelbaum, ... Blood, The Journal of the American Society of Hematology 126 (8), 1033-1040, 2015 | 678 | 2015 |
Cord-blood engraftment with ex vivo mesenchymal-cell coculture M De Lima, I McNiece, SN Robinson, M Munsell, M Eapen, M Horowitz, ... New England Journal of Medicine 367 (24), 2305-2315, 2012 | 541 | 2012 |
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells P Kebriaei, H Singh, MH Huls, MJ Figliola, R Bassett, S Olivares, B Jena, ... The Journal of clinical investigation 126 (9), 3363-3376, 2016 | 537 | 2016 |
Phase 1 clinical trial using mbIL21 ex vivo–expanded donor-derived NK cells after haploidentical transplantation SO Ciurea, JR Schafer, R Bassett, CJ Denman, K Cao, D Willis, ... Blood, The Journal of the American Society of Hematology 130 (16), 1857-1868, 2017 | 334 | 2017 |
High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation SO Ciurea, M De Lima, P Cano, M Korbling, S Giralt, EJ Shpall, X Wang, ... Transplantation 88 (8), 1019-1024, 2009 | 307 | 2009 |
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors AS Kanate, A Mussetti, MA Kharfan-Dabaja, KW Ahn, A DiGilio, ... Blood, The Journal of the American Society of Hematology 127 (7), 938-947, 2016 | 292 | 2016 |
Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation SO Ciurea, V Mulanovich, RM Saliba, UD Bayraktar, Y Jiang, R Bassett, ... Biology of Blood and Marrow Transplantation 18 (12), 1835-1844, 2012 | 292 | 2012 |
Mobilized peripheral blood stem cells versus unstimulated bone marrow as a graft source for T-cell–replete haploidentical donor transplantation using post-transplant … A Bashey, MJ Zhang, SR McCurdy, A St. Martin, T Argall, C Anasetti, ... Journal of Clinical Oncology 35 (26), 3002-3009, 2017 | 283 | 2017 |
Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen–matched unrelated and … A Di Stasi, DR Milton, LM Poon, A Hamdi, G Rondon, J Chen, SR Pingali, ... Biology of Blood and Marrow Transplantation 20 (12), 1975-1981, 2014 | 255 | 2014 |
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States L Muffly, MC Pasquini, M Martens, R Brazauskas, X Zhu, K Adekola, ... Blood, The Journal of the American Society of Hematology 130 (9), 1156-1164, 2017 | 254 | 2017 |
Busulfan in hematopoietic stem cell transplantation SO Ciurea, BS Andersson Biology of Blood and Marrow Transplantation 15 (5), 523-536, 2009 | 254 | 2009 |
Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation SO Ciurea, PF Thall, X Wang, SA Wang, Y Hu, P Cano, F Aung, ... Blood, The Journal of the American Society of Hematology 118 (22), 5957-5964, 2011 | 249 | 2011 |
Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis SO Ciurea, D Merchant, N Mahmud, T Ishii, Y Zhao, W Hu, E Bruno, ... Blood, The Journal of the American Society of Hematology 110 (3), 986-993, 2007 | 240 | 2007 |
The European Society for Blood and Marrow Transplantation (EBMT) consensus guidelines for the detection and treatment of donor-specific anti-HLA antibodies (DSA) in … SO Ciurea, K Cao, M Fernandez-Vina, P Kongtim, MA Malki, E Fuchs, ... Bone marrow transplantation 53 (5), 521-534, 2018 | 237 | 2018 |
Complement-binding donor-specific anti-HLA antibodies and risk of primary graft failure in hematopoietic stem cell transplantation SO Ciurea, PF Thall, DR Milton, TH Barnes, P Kongtim, Y Carmazzi, ... Biology of Blood and Marrow Transplantation 21 (8), 1392-1398, 2015 | 206 | 2015 |
The natural history and treatment outcome of blast phase BCR-ABL− myeloproliferative neoplasms CS Tam, RM Nussenzveig, U Popat, CE Bueso-Ramos, DA Thomas, ... Blood, The Journal of the American Society of Hematology 112 (5), 1628-1637, 2008 | 206 | 2008 |
Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation U Popat, RS Mehta, K Rezvani, P Fox, K Kondo, D Marin, I McNiece, ... Blood, The Journal of the American Society of Hematology 125 (19), 2885-2892, 2015 | 151 | 2015 |
The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation SO Ciurea, MM Al Malki, P Kongtim, EJ Fuchs, L Luznik, XJ Huang, ... Bone marrow transplantation 55 (1), 12-24, 2020 | 144 | 2020 |
Haploidentical natural killer cells infused before allogeneic stem cell transplantation for myeloid malignancies: a phase I trial DA Lee, CJ Denman, G Rondon, G Woodworth, J Chen, T Fisher, I Kaur, ... Biology of Blood and Marrow Transplantation 22 (7), 1290-1298, 2016 | 144 | 2016 |